8126 related articles for article (PubMed ID: 1805570)
1. Paucity of humoral response in patients to glioma-associated antigen(s): antigen localization by immunofluorescence.
Fischer DK; Matsuda M; Shaban F; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():263-70. PubMed ID: 1805570
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of antisera and of murine monoclonal antibodies to human glioma-associated antigen(s).
Matsuda M; Fischer DK; Narayan RK; Atassi MZ
Adv Exp Med Biol; 1991; 303():271-83. PubMed ID: 1805572
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
[TBL] [Abstract][Full Text] [Related]
4. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
Abaza MS; Shaban F; Narayan RK; Atassi MZ
Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines.
Abaza MS; Narayan RK; Atassi MZ
Jpn J Cancer Res; 1997 Nov; 88(11):1094-9. PubMed ID: 9439685
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response in melanoma and glioma patients: a solubilized melanoma-membrane component as a tool for detecting circulating antibodies.
Birkmayer GD
Cancer; 1981 Dec; 48(11):2399-408. PubMed ID: 7296490
[TBL] [Abstract][Full Text] [Related]
7. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
[TBL] [Abstract][Full Text] [Related]
8. Malignant glial neoplasms: definition of a humoral host response to tumor-associated antigen(s).
Sheikh KM; Apuzzo ML; Kochsiek KR; Weiss MH
Yale J Biol Med; 1977; 50(4):397-403. PubMed ID: 333792
[TBL] [Abstract][Full Text] [Related]
9. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
10. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
11. Patterns of antigenic expression of human glioma cells.
McKeever PE; Davenport RD; Shakui P
Crit Rev Neurobiol; 1991; 6(2):119-47. PubMed ID: 1934088
[TBL] [Abstract][Full Text] [Related]
12. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
13. Humoral immune response in glioma patients: A solubilized glioma-associated membrane antigen as a tool for detecting circulating antibodies.
Birkmayer GD; Stass HP
Int J Cancer; 1980 Apr; 25(4):445-52. PubMed ID: 6768679
[TBL] [Abstract][Full Text] [Related]
14. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
15. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies.
Abaza MS; Shaban FA; Narayan RK; Atassi MZ
Br J Cancer; 1998 Dec; 78(12):1578-85. PubMed ID: 9862567
[TBL] [Abstract][Full Text] [Related]
17. The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.
Apuzzo ML; Sheikh KM; Weiss MH; Heiden JS; Kurze T
Acta Neurochir (Wien); 1981; 55(3-4):181-200. PubMed ID: 7015801
[TBL] [Abstract][Full Text] [Related]
18. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
[TBL] [Abstract][Full Text] [Related]
19. Human glioma-associated antigens detected by monoclonal antibodies.
Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
